α-hederin inhibits cervical cancer progression by inducing DNA damage-dependent cell cycle blockade and apoptosis
α-hederin may be an effective drug to inhibit cervical cancer and has a good development prospect.
Authors
- Feng‐Lian Yang (ORCID: https://orcid.org/0009-0008-8001-4053)
- Rong Wang (ORCID: https://orcid.org/0000-0001-6904-806X)
- Xin Zhang (ORCID: https://orcid.org/0000-0002-4438-7337)
- Junli Wang (ORCID: https://orcid.org/0000-0001-6862-1944)
- Jingxin Wang (ORCID: https://orcid.org/0000-0002-9414-4093)
- Yuanlin Song (ORCID: https://orcid.org/0000-0002-9826-4383)
- Yuehua Huang (ORCID: https://orcid.org/0000-0002-0982-3551)
- Ziqi Lin
- Shaofeng Huang (ORCID: https://orcid.org/0000-0002-2565-0005)
- Hai-Mei Qin
Institutions
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
- Baise University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1186/s12885-025-14920-4
- Citations
- 1
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Natural Science Foundation of Guangxi Province
- Division of Graduate Education